Romano Brothers & Co’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $337K | Sell |
4,883
-1,490
| -23% | -$103K | 0.04% | 259 |
|
|
2025
Q1 | $443K | Buy |
6,373
+45
| +0.7% | +$3.13K | 0.06% | 224 |
|
|
2024
Q4 | $544K | Buy |
6,328
+680
| +12% | +$58.5K | 0.07% | 205 |
|
|
2024
Q3 | $673K | Buy |
5,648
+20
| +0.4% | +$2.38K | 0.08% | 187 |
|
|
2024
Q2 | $803K | Buy |
5,628
+170
| +3% | +$24.3K | 0.11% | 168 |
|
|
2024
Q1 | $701K | Sell |
5,458
-160
| -3% | -$20.5K | 0.1% | 180 |
|
|
2023
Q4 | $581K | Sell |
5,618
-760
| -12% | -$78.6K | 0.09% | 184 |
|
|
2023
Q3 | $580K | Buy |
6,378
+650
| +11% | +$59.1K | 0.09% | 185 |
|
|
2023
Q2 | $463K | Buy |
5,728
+208
| +4% | +$16.8K | 0.07% | 214 |
|
|
2023
Q1 | $439K | Buy |
5,520
+2,170
| +65% | +$173K | 0.07% | 220 |
|
|
2022
Q4 | $227K | Buy |
+3,350
| New | +$227K | 0.03% | 282 |
|